{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:40:51Z","timestamp":1790764851551,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ekir.2022.10.008","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T03:42:53Z","timestamp":1665978173000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous Nephropathy"],"prefix":"10.1016","volume":"8","author":[{"given":"Maxime","family":"Teisseyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Beyze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Perrochia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Szwarc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Champion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Chenine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Broner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Aglae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2022.10.008_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.10.008_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI109987","article-title":"A\u00a0new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2022.10.008_bib3","first-page":"121","article-title":"Membrane attack complex deposition in experimental glomerular injury","volume":"120","author":"Perkinson","year":"1985","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2022.10.008_bib4","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4049\/jimmunol.137.5.1511","article-title":"The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy","volume":"137","author":"Cybulsky","year":"1950","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib5","article-title":"Anti-PLA2R1 antibodies containing sera induce in\u00a0vitro cytotoxicity mediated by complement activation","volume":"2019","author":"Lateb","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.ekir.2022.10.008_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.1988.56","article-title":"Idiopathic membranous nephropathy: the natural history of untreated patients","volume":"33","author":"Donadio","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.10.008_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2019.00235","article-title":"C5b9 deposition in glomerular capillaries is associated with poor kidney allograft survival in antibody-mediated rejection","volume":"10","author":"Goutaudier","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib8","first-page":"86","article-title":"KDIGO clinical practice guideline for glomerulonephritis","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2022.10.008_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","article-title":"Molecular pathogenesis of membranous nephropathy","volume":"15","author":"Ronco","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ekir.2022.10.008_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.semnephrol.2013.08.004","article-title":"The role of complement in membranous nephropathy","volume":"33","author":"Ma","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2022.10.008_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-3083.1985.tb01870.x","article-title":"Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma","volume":"22","author":"Mollnes","year":"1985","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1523-1755.1998.00130.x","article-title":"Complement regulatory proteins in glomerular diseases","volume":"54","author":"Nangaku","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.10.008_bib13","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1172\/JCI119768","article-title":"Pathogenic antibodies inhibit the binding of apolipoproteins to megalin\/gp330 in passive Heymann nephritis","volume":"100","author":"Kerjaschki","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2022.10.008_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1172\/JCI117499","article-title":"Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen","volume":"94","author":"Neale","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2022.10.008_bib15","first-page":"1313","article-title":"Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis","volume":"149","author":"Exner","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2022.10.008_bib16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ki.1995.224","article-title":"Active Heymann nephritis in complement component C6 deficient rats","volume":"47","author":"Leenaerts","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.10.008_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.179.1.172","article-title":"Induction of passive Heymann nephritis in complement component 6-deficient PVG rats","volume":"179","author":"Spicer","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib18","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4049\/jimmunol.1003451","article-title":"Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis","volume":"187","author":"Meyer-Schwesinger","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib19","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ekir.2022.10.008_bib20","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1681\/ASN.2017010030","article-title":"A\u00a0heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"28","author":"Tomas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.10.008_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.2018090941","article-title":"Thrombospondin type 1 domain-containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes","volume":"30","author":"Herwig","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.10.008_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/eci.12292","article-title":"Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen","volume":"44","author":"\u0160koberne","year":"2014","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ekir.2022.10.008_bib23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ki.1992.143","article-title":"Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy","volume":"41","author":"Brenchley","year":"1992","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.10.008_bib24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ki.1995.496","article-title":"Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy","volume":"48","author":"Kon","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2022.10.008_bib25","first-page":"668A","article-title":"Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy","volume":"13","author":"Appel","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2022.10.008_bib26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3389\/fimmu.2019.02166","article-title":"Complement inhibitors in clinical trials for glomerular diseases","volume":"10","author":"Zipfel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2022.10.008_bib27","first-page":"133","article-title":"The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party","volume":"74","author":"Cameron","year":"1990","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.ekir.2022.10.008_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A\u00a0randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.10.008_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/ajkd.2000.8968","article-title":"Use of mycophenolate mofetil in resistant membranous nephropathy","volume":"36","author":"Miller","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2022.10.008_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2022.10.008_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922018204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024922018204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:47:27Z","timestamp":1762832847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024922018204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2468024922018204"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2022.10.008","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C5b-9 Glomerular Deposits Are Associated With Poor Renal Survival in Membranous Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2022.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}